IR
Superintel
OverviewMarketsWatchlist
© 2026 IR SuperintelMethodologyContact

Teva Pharmaceutical Finance Netherlands III BV

Q3 2025 vs Q4 2025

Comparing institutional holders between quarters

Quarters

Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024
CompareDetailedHistoricalFundsOptionsShort Interest13D/13GPeersTargetingTrading SummaryProfile
Pacer Advisors, Inc.
INCREASED
Shares75,000 from 22,000
Change+53,000 (+241%)
Value$86.4K (+$61.2K)
Filed 2026-02-24
Status
Pacer Advisors, Inc.
INCREASED75,00022,000+53,000+241%$25.2K$86.4K+$61.2K2026-02-24
Showing 1 of 1 institutions